Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget.
Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
Wafik El-Deiry shared a few must-reads paper on X:
Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer
Authors: Ronald Fowle-Grider et al.
Authors: Jean-Philippe Guégan et al.
Telemedicine-based exercise intervention in cancer survivors: a non-randomized controlled trial
Authors: Verena Krell et al.
Control of Cellular Differentiation Trajectories for Cancer Reversion
Authors: Jeong-Ryeol Gong et al.
Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures
Authors: Ivan Milenkovic et al.
